Florentine Hilbers

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

Martine Piccart, Laura van ‘t Veer, Coralie Poncet et al. · The Lancet Oncology · 2021 · 358 citations · Full text

Life Sciences, Biostatistics, Oncology +13

Rare Mutations in XRCC2 Increase the Risk of Breast Cancer

Daniel J. Park, Fabienne Lesueur, Tú Nguyen‐Dumont et al. · The American Journal of Human Genetics · 2012 · 183 citations · Full text

Life Sciences, Genetics, Molecular Genetics +8

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative

Philippe Aftimos, Mafalda Oliveira, Alexandre Irrthum et al. · Cancer Discovery · 2021 · 177 citations · Full text

Medicine, Genetics, Oncology +17

Whole Exome Sequencing Suggests Much of Non-BRCA1/BRCA2 Familial Breast Cancer Is Due to Moderate and Low Penetrance Susceptibility Alleles

Francisco Javier Gracia-Aznárez, María Victoria Fernández, Guillermo Pita et al. · PLoS ONE · 2013 · 100 citations · Full text

Life Sciences, Genetics, Oncology +17

<i>FANCM</i>c.5791C&gt;T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor

Paolo Peterlongo, Irene Catucci, Mara Colombo et al. · Human Molecular Genetics · 2015 · 96 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17